£2.6M
Catapult Ventures led the seed round alongside Neo Kuma Ventures, Wren Capital, and o2H ventures to support the Cambridge Cognition spinout.
Monument Therapeutics
Monument Therapeutics develops stratified treatments for central nervous system conditions using digital brain biomarkers.
£2.6MTotal raised
Monument Therapeutics is a stratified medicine company applying digital biomarkers to neuroscience drug development. The firm focuses on matching patient sub-groups with targeted compounds.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Net assets
Members only
Current assets
Members only
Employees
Members only
Cash, assets and headcount from Monument Therapeutics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
Jenny Barnett
Chief Executive Officer
Jenny is the chief executive officer of Monument Therapeutics and chief scientific officer at Five Lives. She also serves as a research fellow at the University of Cambridge and a by-fellow at Hughes Hall.
LinkedIn